Contribution of Kinins to Endotoxin Shock in Unanesthetized Rhesus Monkeys

¹ Cardiovascular Research Institute, and from the Departments of Medicine and Pharmacology, University of California San Francisco Medical Center, San Francisco, California 94122
² Cardiovascular Research Institute, and from the Departments of Medicine and Pharmacology, University of California San Francisco Medical, Center San Francisco, California 94122

The effects of endotoxin (Escherichia coli and Pseudomonas pseudomallei) were studied in 18 unanesthetized rhesus monkeys restrained in primate chairs. Indwelling arterial and venous catheters were used for hemodynamic measurements and blood sampling. Whole blood kinin, plasma kininogen, lysosomal enzymes, complete blood counts, and blood gas tensions were measured. Within an hour of beginning the infusion of the endotoxin, the mean arterial pressure and systemic peripheral resistance decreased significantly in the 18 experimental monkeys compared to 13 control monkeys. These early changes were associated with significant elevation in whole blood kinin concentration and a decrease in plasma kininogen. All of these early changes were most marked in the animals that died. Granulocytopenia occurred within 15 minutes, and the concentration of free lysosomal enzyme in the plasma rose 2 hours after endotoxin infusion. The preterminal phase of shock was characterized by a low peripheral vascular resistance and decreasing cardiac output without elevation of kinin levels. These findings support the hypothesis that kinins play a pathogenetic role in the early phase of endotoxin-induced shock and that the severity of the early phase may influence the animal's survival. The relation of kinins to other vasoactive substances released after endotoxin-induced shock is unknown.

Accepted on December 9, 1967

This article has been cited by other articles:

				C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension FASEB J, June 1, 2007; 21(8): 1689 - 1698. [Abstract] [Full Text] [PDF]

				J. N. Sharma Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview J. Clin. Pharmacol., November 1, 2003; 43(11): 1187 - 1195. [Abstract] [Full Text] [PDF]

				P. G. McLean, M. Perretti, and A. Ahluwalia Kinin B1 receptors and the cardiovascular system: regulation of expression and function Cardiovasc Res, November 1, 2000; 48(2): 194 - 210. [Abstract] [Full Text] [PDF]

				K. Kishi, K. Hirai, K. Hiramatsu, T. Yamasaki, and M. Nasu Clindamycin Suppresses Endotoxin Released by Ceftazidime-Treated Escherichia coli O55:B5 and Subsequent Production of Tumor Necrosis Factor Alpha and Interleukin-1beta Antimicrob. Agents Chemother., March 1, 1999; 43(3): 616 - 622. [Abstract] [Full Text]

				P. R. Forfia, X. Zhang, F. Ochoa, M. Ochoa, X. Xu, R. Bernstein, P. B. Sehgal, N. R. Ferreri, and T. H. Hintze Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H193 - H201. [Abstract] [Full Text] [PDF]

				R.C. Bone Sepsis and the systemic inflammatory response syndrome (SIRS) Innate Immunity, June 1, 1995; 2(3): 151 - 155. [PDF]

				A. O. Aasen, N. Smith-Erichsen, and E. Amundsen Plasma Kallikrein-Kinin System in Septicemia Arch Surg, March 1, 1983; 118(3): 343 - 346. [Abstract] [PDF]

				T. YAMADA, P. HARBER, G. W. PETTIT, D. A. WING, and C. N. OSTER Activation of the Kallikrein-Kinin System in Rocky Mountain Spotted Fever Ann Intern Med, June 1, 1978; 88(6): 764 - 768. [Abstract] [PDF]

				E. L. Howes Jr. and D. G. McKay Circulating Immune Complexes: Effects on Ocular Vascular Permeability in the Rabbit Arch Ophthalmol, May 1, 1975; 93(5): 365 - 370. [Abstract] [PDF]

				J. LEVIN, T. E. POORE, N. S. YOUNG, S. MARGOLIS, N. P. ZAUBER, A. S. TOWNES, and W. R. BELL Gram-Negative Sepsis: Detection of Endotoxemia with the Limulus Test: With Studies of Associated Changes in Blood Coagulation, Serum Lipids, and Complement Ann Intern Med, January 1, 1972; 76(1): 1 - 7. [Abstract] [PDF]

				J. W. MASON, U. KLEEBERG, P. DOLAN, and R. W. COLMAN Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia Ann Intern Med, October 1, 1970; 73(4): 545 - 551. [Abstract] [PDF]

				L. B. Hinshaw, L. L. Shanbour, L. J. Greenfield, and J. J. Coalson Mechanism of Decreased Venous Return: Subhuman Primate-Administered Endotoxin Arch Surg, May 1, 1970; 100(5): 600 - 606. [Abstract] [PDF]

				R. W. COLMAN, J. W. MASON, and S. SHERRY The Kallikreinogen-Kallikrein Enzyme System of Human Plasma: Assay of Components and Observations in Disease States Ann Intern Med, October 1, 1969; 71(4): 763 - 773. [Abstract] [PDF]

				D. Cavanagh and P. S. Rao Endotoxin Shock in the Subhuman Primate: I. Hemodynamic and Biochemical Changes Arch Surg, July 1, 1969; 99(1): 107 - 112. [Abstract] [PDF]